Carmell (NASDAQ:CTCX) Shares Down 2.8% - Time to Sell?

Shares of Carmell Co. (NASDAQ:CTCX - Get Free Report) fell 2.8% on Thursday . The stock traded as low as $2.38 and last traded at $2.45. 18,767 shares changed hands during trading, a decline of 100% from the average session volume of 4,290,529 shares. The stock had previously closed at $2.52.

Carmell Trading Up 0.8%

The company's fifty day moving average price is $2.09 and its two-hundred day moving average price is $0.91.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Carmell stock. Antara Capital LP purchased a new stake in Carmell Co. (NASDAQ:CTCX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 100,000 shares of the company's stock, valued at approximately $28,000. Carmell accounts for about 0.0% of Antara Capital LP's holdings, making the stock its 10th largest holding. Antara Capital LP owned approximately 0.48% of Carmell at the end of the most recent reporting period. Institutional investors and hedge funds own 24.22% of the company's stock.

About Carmell

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.